Table 3.
China n = 154 |
Egypt n = 186 |
India n = 127 |
Japan n = 864 |
Korea n = 105 |
|
---|---|---|---|---|---|
MTAs should require that foreign collaborating scientists consult local scientists before any new use of samples | 138 89.6% |
170 91.4% |
118 92.9% |
1011 67.7% |
82 78.1% |
MTAs should require local scientists to have some decision making power over the future use of samples | 132 85.7% |
169 90.9% |
108 85% |
484 56.1% |
76 72.3% |
MTAs should require that decisions regarding future use of samples should be made jointly by a committee composed of representatives of both local and foreign scientists | 110 71.4% |
162 87.1% |
106 83.5% |
461 53.4% |
72 68.5% |
MTAs should require that local scientists have veto power over any future use of samples by foreign collaborating scientists | 98 63.7% |
156 83.8% |
88 69.2% |
410 47.5% |
73 69.5% |
MTAs should require that a local scientist is involved in the protocol development team for any future research on the samples | 130 84.4% |
165 88.7% |
103 81.1% |
457 52.9% |
70 66.2% |